Whalegun
Home

Alnylam Pharmaceuticals ALNY paid Capitol Counsel $30K for lobbying in Q2 2026 · Medical

Trade details

Type
Lobbying report
Amount
$30,000
Quarter
Q2 2026
Stock
Alnylam Pharmaceuticals ALNY
Client
Alnylam Pharmaceuticals
Reported
26/07/16

Down 50.0% from last quarter

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Alnylam Pharmaceuticals's other lobbying reports